Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study.
Rom J, von Minckwitz G, Eiermann W, Sievert M, Schlehe B, Marmé F, Schuetz F, Scharf A, Eichbaum M, Sinn HP, Kaufmann M, Sohn C, Schneeweiss A. Rom J, et al. Among authors: sievert m. Ann Oncol. 2008 Oct;19(10):1698-705. doi: 10.1093/annonc/mdn280. Epub 2008 May 13. Ann Oncol. 2008. PMID: 18477581 Free article. Clinical Trial.
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
Al-Batran SE, Hartmann JT, Hofheinz R, Homann N, Rethwisch V, Probst S, Stoehlmacher J, Clemens MR, Mahlberg R, Fritz M, Seipelt G, Sievert M, Pauligk C, Atmaca A, Jäger E. Al-Batran SE, et al. Among authors: sievert m. Ann Oncol. 2008 Nov;19(11):1882-7. doi: 10.1093/annonc/mdn403. Epub 2008 Jul 31. Ann Oncol. 2008. PMID: 18669868 Free article. Clinical Trial.
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Al-Batran SE, Hofheinz RD, Pauligk C, Kopp HG, Haag GM, Luley KB, Meiler J, Homann N, Lorenzen S, Schmalenberg H, Probst S, Koenigsmann M, Egger M, Prasnikar N, Caca K, Trojan J, Martens UM, Block A, Fischbach W, Mahlberg R, Clemens M, Illerhaus G, Zirlik K, Behringer DM, Schmiegel W, Pohl M, Heike M, Ronellenfitsch U, Schuler M, Bechstein WO, Königsrainer A, Gaiser T, Schirmacher P, Hozaeel W, Reichart A, Goetze TO, Sievert M, Jäger E, Mönig S, Tannapfel A. Al-Batran SE, et al. Among authors: sievert m. Lancet Oncol. 2016 Dec;17(12):1697-1708. doi: 10.1016/S1470-2045(16)30531-9. Epub 2016 Oct 22. Lancet Oncol. 2016. PMID: 27776843 Clinical Trial.
Symptom Burden and Quality of Life in Long-Term Survivors with Head and Neck Cancer.
Gostian M, Allner M, Rak A, Balk M, Rupp R, Ostgathe C, Mantsopoulos K, Sievert M, Iro H, Hecht M, Gostian AO. Gostian M, et al. Among authors: sievert m. Ear Nose Throat J. 2024 Dec 9:1455613241276776. doi: 10.1177/01455613241276776. Online ahead of print. Ear Nose Throat J. 2024. PMID: 39651655 Free article.
Measuring Growth, Resistance, and Recovery after Artemisinin Treatment of Plasmodium falciparum in a single semi-high-throughput Assay.
Sievert MAC, Singh PP, Shoue DA, Checkley LA, Brenneman KM, Qahash T, Cassady Z, Kumar S, Li X, Nosten FH, Anderson TJC, Vaughan AM, Romero-Severson J, Ferdig MT. Sievert MAC, et al. bioRxiv [Preprint]. 2024 Nov 11:2024.11.11.623064. doi: 10.1101/2024.11.11.623064. bioRxiv. 2024. PMID: 39605531 Free PMC article. Preprint.
The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh Plasmodium falciparum isolates.
Okitwi M, Shoue DA, Checkley LA, Orena S, Ceja FG, Taremwa Y, Tumwebaze PK, Katairo T, Byaruhanga O, Sievert MA, Garg S, Kreutzfeld OK, Legac J, Bailey JA, Nsobya SL, Conrad MD, Rosenthal PJ, Ferdig MT, Cooper RA. Okitwi M, et al. Among authors: sievert ma. Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0118324. doi: 10.1128/aac.01183-24. Epub 2024 Nov 15. Antimicrob Agents Chemother. 2024. PMID: 39545737
171 results